1. Pink Sheet
  2. >>Market Access
  3. >>Pricing Debate

HHS Senior Advisor O’Brien Emerges As Azar’s Lead On Drug Pricing In 2019

 
• By Ramsey Baghdadi

O’Brien assumes role from his late colleague and friend Dan Best as HHS closes out administrative items in the blueprint.

RollOfDollarswithPills_1200x675

The Trump Administration appears to be ramping up towards some kind of action on drug pricing early in the New Year.

Over the last two weeks, HHS Secretary Alex Azar has been posting regular pictures of meetings with a variety of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Pricing Debate

More from Market Access